X4 Pharmaceuticals, Inc (XFOR)
Latest XFOR Insider Trades
John Volpone - OfficerOpen-market sale$109K- Adam R. Craig - OfficerOpen-market sale$211K
About X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
- BOSTON, MA
- 45
- 2017
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 80,555 | $356K |
| Grant or award | 1 | 110,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
XFOR Insider Transactions (Form 4)
3322 Form 4 filings on record, the earliest from Oct 8, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Volpone - Officer | Open-market sale | Common Stock |
Recent XFOR Form 8-K Filings
3Recent XFOR Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| John Volpone | Officer | 24,576 | $112K | View on EDGAR | |
| Adam Craig | Executive Chaiman |
XFOR Insider Trading - FAQ
What is the latest insider trade for XFOR?
X4 Pharmaceuticals, Inc (XFOR) had 4 insider filings in the last 90 days, with the most recent on 2026-08-13. The full record for XFOR runs to 22 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying XFOR stock?
No insider purchases of XFOR were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling XFOR stock?
3 insider sales of XFOR were filed in the last 90 days, totaling $356K.
Where can I see XFOR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks XFOR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow XFOR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add XFOR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - John Volpone view on EDGAR
- - Adam R. Craig view on EDGAR
- - David Kirske view on EDGAR
- - Kelly Gold view on EDGAR
- - David Kirske view on EDGAR
- - John Volpone view on EDGAR
- - David Kirske view on EDGAR
- - Adam R. Craig view on EDGAR
- - Adam R. Craig view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where XFOR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track XFOR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
